M. Bollinger

发表

OMALIZUMAB PROVIDES LONG-TERM CONTROL IN PATIENTS WITH MODERATE-TO-SEVERE ALLERGIC ASTHMA

E. Matsui, R. Wood, M. Bollinger, 2003 .

A School-Based Case Identification Process for Identifying Inner City Children With Asthma: The Breathmobile Program

M. Bollinger, 2005, Pediatrics.

Reduction in mouse allergen exposure is associated with greater lung function growth.

R. Peng, W. Phipatanakul, R. Wise, 2018, The Journal of allergy and clinical immunology.

Salmeterol Powder Provides Significantly Better Benefit than Montelukast in Asthmatic Patients Receiving Concommitant Inhaled Corticosteroid Therapy

M. Bollinger, 2002, Pediatrics.

Tolerance to the Protective Effect of Salmeterol on Allergen Challenge Can be Partially Restored by Withdrawal of Salmeterol Regular Treatment

M. Bollinger, 2002, Pediatrics.

Effect of Salmeterol on Allergen-Induced Airway Inflammation in Mild Allergic Asthma

M. Bollinger, 2002, Pediatrics.

NATURAL COURSE OF SENSITIZATION TO COW’S MILK AND HEN′S EGG IN CHILDHOOD ATOPIC DERMATITIS: THE ETAC STUDY GROUP

B. Mark, M. Bollinger, 2003, Pediatrics.

Environmental Tobacco Smoke Exposure During Childhood is Associated with Increased Prevalence of Asthma in Adults

M. Bollinger, 2002, Pediatrics.

INVOLUNTARY SMOKING AND ASTHMA SEVERITY IN CHILDREN: DATA FROM THE THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES III)

M. Bollinger, 2003, Pediatrics.

Late Eczematous Reactions to Food in Children With Atopic Dermatitis

L. Gober, M. Bollinger, 2005, Pediatrics.

Sleep architecture and behavioral abnormalities in children and adolescents

P. Langenberg, C. Blaisdell, T. Achenbach, 2010, International journal of adolescent medicine and health.

ROLE OF GASTROESOPHAGEAL REFLUX IN OLDER CHILDREN WITH PERSISTENT ASTHMA

M. Bollinger, 2004, Pediatrics.